News
For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...
Royalty Pharma reported 12% growth in Q1 royalty receipts, driven by Vertex, GSK, and Roche. Read why RPRX stock is a Buy.
The dollar has weakened against rival currencies since Trump started his second term. One strategist says the US currency is ...
Even as Roche makes a major investment pledge across its U.S. business, the Swiss pharmaceutical giant isn’t neglecting its ...
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech ...
Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...
Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...
A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...
As the nearly 130-year-old pharmaceutical company consolidated its CRM systems, it cut down on vendor costs and paved the way ...
GlobalData on MSN12d
FDA grants breakthrough status to Roche’s VENTANA TROP2 deviceThe device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...
Germain, in collaboration with Novotel, is delighted to unveil the Legendary Room celebrating Alain Roche at Novotel Valencia ...
The Prime Minister finally has a new chief science adviser, almost a year after his former adviser stepped down. Ministry of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results